Combination of etanidazole with cyclophosphamide and platinum complexes Beverly A. TeicherTerence S. HermanEmil Frei III Original Articles Pages: 153 - 158
Pentetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapy Gerrit LosEls M. E. VerdegaalJ. Gordon McVie Original Articles Pages: 159 - 165
L-Cysteine prodrug protects against cyclophosphamide urotoxicity without compromising therapeutic activity Jeanette C. RobertsDavid J. FranceticRichard T. Zera Original Articles Pages: 166 - 170
Myocardial toxicity of high-dose cyclophosphamide in rabbits treated with daunorubicin Bengt IsbergChrister PaulUlla Svahn Original Articles Pages: 171 - 180
The mechanism of differential sensitivity to methotrexate of normal and malignant human epidermal cells Myung-Moo LeeJudson RatliffMichael M. Wick Original Articles Pages: 181 - 184
Antibodies against cisplatin-modified DNA and cisplatin-modified (di) nucleotides P. M. A. B. TerheggenB. G. J. FlootL. den Engelse Original Articles Pages: 185 - 191
Antitumor activity of a camptothecin derivative, CPT-11, against human tumor xenografts in nude mice Yasuyoshi KawatoTomio FurutaKensuke Matsumoto Original Articles Pages: 192 - 198
Alleviation by leucovorin of the dose-limiting toxicity of edatrexate: potential for improved therapeutic efficacy Jin S. LeeWilliam K. MurphyWaun K. Hong Original Articles Pages: 199 - 204
A pharmacokinetic study of prednimustine as compared with prednisolone plus chlorambucil in cancer patients Lars BastholtCarl-Johan JohanssonHenning Mouridsen Original Articles Pages: 205 - 210
Treatment of non-small-cell lung cancer with vinblastine and very high-dose cisplatin. A Southwest Oncology Group study Steven M. GrunbergJohn J. CrowleyRonald L. Stephens Original Articles Pages: 211 - 213
Unaltered pharmacokinetics after the administration of high-dose etoposide without prior dilution G. EhningerB. ProkschR. Dopfer Original Articles Pages: 214 - 216
Case report of metastatic familial pheochromocytoma treated with cisplatin and 5-fluorouracil Vichien SrimuninnimitGalen L. Wampler Original Articles Pages: 217 - 219
Epirubicin: A phase II study in recurrent small-cell lung cancer Mark RosenthalRichard KeffordRobin Stuart-Harris Original Articles Pages: 220 - 222
Phase II trial of trimetrexate in patients with advanced soft-tissue sarcoma Jonathan D. LichtRené GoninKaren H. Antman Short Communication Pages: 223 - 225
Double-blind, randomized crossover study of metoclopramide and batanopride for prevention of cisplatin-induced emesis Gini F. FlemingEverett E. VokesLaurie Smaldone Short Communication Pages: 226 - 227
Inhibition of mitomycin C's aerobic toxicity by the seleno-organic antioxidant PZ-51 Daniel L. GustafsonChris A. Pritsos Short Communication Pages: 228 - 230
Single-dose i.v. dexamethasone—an effective anti-emetic in cancer chemotherapy Huw ParryKim Martin Short Communication Pages: 231 - 232
Low-dose methotrexate therapy for hepatoblastoma Steven D. WeitmanGregory J. KatoBarton A. Kamen Letter to the Editors Pages: 233 - 234